Neonatal Medicine News

Hemangeol was found to have a good overall safety profile as treatment for healthy children with infantile hemangioma, according to a study using a nationwide claims database in France.

WASHINGTON, D.C. — Children exposed to anti-TNF alpha in utero do not have a higher risk for developing tuberculosis following a Bacillus Calmette-Guerin vaccination, according to research presented at Digestive Disease Week.

WASHINGTON, D.C. — Oral iron supplementation during infancy and diphtheria and polio vaccination appeared to reduce the risk for developing inflammatory bowel disease later in life, according to a presenter here.

Although children born to young mothers are at the highest risk of developmental vulnerabilities, including physical health and well-being as well as language and cognitive skills, a small increase in risk was observed in children born to mothers aged older than 36 years.

Black preterm infants who received vitamin D supplementation until 12 months’ adjusted gestational age were nearly 11% less likely to experience recurrent wheezing when compared with neonates who did not receive the supplementation, according to research published in JAMA.

The FDA issued a warning today that that over-the-counter teething products containing benzocaine pose a serious risk to teething infants and children, and said it is taking steps to stop the sale of such products.

Contemporary neurodevelopmental outcomes have shifted for extremely premature infants, with researchers observing a decrease from severe to more mild motor and sensory impairment, according to findings published in Pediatrics.

Following up with children who experienced unclassified fever in Ethiopia only if they experienced continuing symptoms was noninferior to universal follow-up protocol after 3 days, with only 0.8% of children failing treatment when receiving conditional follow-up.

Women with abnormal 1-hour glucose challenge tests had higher birth weight babies than women with normal test results, according to findings presented at the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting.

Preterm infants born younger than 29 weeks’ gestation who are treated for pulmonary hypoplasia with inhaled nitric oxide do not have an increased chance of in-hospital survival, according to findings published in JAMA Pediatrics.